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n Abstract Coronary artery ecta-
sia (CAE) is defined as a localized
or diffuse non-obstructive lesion
of the epicardial coronary arteries
with a luminal dilation exceeding
1.5-fold the diameter of the nor-
mal adjacent arterial segment.
The incidence of CAE has been
reported to range between 2%
and 4%, which might be an over-
estimation of the true frequency.
The coincidence of CAE with
other systemic vascular dilata-
tions has suggested that the
mechanism underlying CAE is
not only localized to coronary ar-
teries, but also to other vascular
compartments such as aorta or
peripheral veins. Although the
pathophysiology of CAE remains
largely unknown, it was supposed
to represent a variant of coronary
atherosclerosis. This review fo-
cuses on this controversy of
whether CAE and coronary artery
disease (CAD) are two manifesta-
tions of the same underlying pro-
cess. There are clear differences
between CAD and CAE with re-
spect to cardiovascular risk fac-
tors such as diabetes mellitus,
and pathogenic steps in disease
progress such as inflammation or
extracellular matrix remodeling.
As this review will underscore,
the current knowledge of the field
is insufficient to finally clarify the
causative interrelation between
CAE and CAD. The clinical
course and treatment of CAE
mainly depends on its coexistence
with CAD. When coexisting with
CAD, the prognosis and treatment
of CAE are the same as for CAD
alone. In isolated CAE, prognosis
is better and anti-platelet drugs
are the mainstay of treatment.
Surgical treatment can be consid-
ered in selected patients. For clar-
ifying the mechanism underlying
CAE, additional clinical, histo-
pathological and pathophysiologi-
cal investigations are required. In
fact, every patient with CAE
should be evaluated systematically
for pathological changes in other
vascular territories, both in the
arterial system as well as in the
venous system, which might oc-
cur in the disease process.
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Introduction
The clinical relevance and the pathophysiology of
coronary artery ectasia (CAE) have received increas-
ing attention in the last decades. The most com-
monly used angiographic definition of CAE is the
diameter of the ectatic segment measuring more
than 1.5 times the diameter of an adjacent healthy
reference segment (Fig. 1) [21, 82]. The main coro-
nary angiographic characteristics of CAE are im-
paired coronary blood flow, delayed antegrade coro-
nary dye filling, segmental back flow phenomenon
(milking phenomenon) and stasis with local deposi-
tion of dye in dilated coronary segments [48]. CAEwas classified into four distinct types by Markis et
al. [53]. These are in decreasing order of severity:
Type I, diffuse ectasia of two or three vessels; Type
II, diffuse disease in one vessel and localized disease
in another vessel; Type III, diffuse ectasia of one
vessel only; Type IV, localized or segmental ectasia.
Although the etiology of CAE is not fully under-
stood, it has been associated with a diverse spec-
trum of pathologies (Table 1).
The incidence of CAE ranges from 0.2% to 10%
[2, 10, 19, 26, 38, 65, 74, 81, 82, 86] with the largest
ante mortem series found in the Coronary Artery
Surgery Study (CASS) registry (4.9% of 20087 pa-
tients referred for coronary angiography) [82]. The
incidence of CAE in an Indian patient cohort with
ischemic heart disease has been reported to exceed
10% [74]. It is reasonable to expect that the inci-
dence of CAE reported in the literature overestimates
the true frequency in the general population, since
the current gold standard for diagnosis of CAE is
coronary angiography, and patients referred to coro-
nary angiography are pre-selected.
Cardiovascular risk factors
and coronary artery ectasia
Several studies have evaluated the traditional cardio-
vascular risk factors in patients with CAE and com-
pared them in those with CAD. Giannoglu et al. [32]
have reported a male dominance in patients with
CAE. This gender difference has been reported pre-
viously [38, 81] and supposed due to the lower inci-
dence of CAD in women, although the relation be-
tween CAE and CAD is not fully understood [32].
Moreover, the higher likelihood of males having
CAE compared with women is generally consistent
with a study in Spain in which male gender was
demonstrated as an independent factor that in-
creased the hazard of CAE [11]. Age has been shown
to constitute a significant factor that is inversely as-
sociated with the presence of CAE [32]. A similar
finding of significantly younger age among patients
with CAE compared to those without CAE has pre-
viously been reported [11, 21, 82]. On the other
hand, Markis et al. [53] have reported comparable
sex and mean age in patients with CAE and patients
with CAD. Although contradictory results were re-
ported [21], hypertension and dyslipidemia were
also reported to be implicated in the pathogenesis of
CAE [10, 31, 53]. Smoking was found to be more
common in patients with CAE than in those with
CAD [11]. Cocain use was also found to be an inde-
pendent predictor of CAE in which smoking was ex-
cluded from the model [67].
Among cardiovascular risk factors, diabetes melli-
tus has taken our attention by independently and in-
versely associating with CAE. Diabetes mellitus is a
well known risk factor positively associated with
coronary atherosclerosis and its complications, i.e.
cardiovascular events [7, 29, 45]. Effects of diabetes
mellitus on progression of atherosclerosis have been
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Fig. 1 Coronary angiogram showing ectasia af-
fecting the proximal portion of the left anterior
descending coronary artery (a) and right coronary
artery (b) of the same patient
Table 1 Pathological entities associated with coronary artery ectasia
Coronary atherosclerosis [21, 53, 82]
Kawasaki disease [18, 39]
Congenital [16, 17, 71, 90, 100]
Familial hypercholesterolemia [80]
Infections [20, 36]
Collagen vascular disease
Ehler-Danlos syndrome [75]
Systemic Lupus erythematosus [54]
Polyarteritis Nodosa [83]
Sclerodema [15]
Juvenile idiopathic arthritis [12]
Takayasu’s disease [59]
Cardiac lymphoma [31]
Cocain use [67]shown by the demonstration of increased carotid ar-
tery intima-media thickness [64, 95]. Androulakis et
al. [5] and Bermudez et al. [11] have reported signif-
icant independent and inverse association between
CAE and diabetes mellitus. Supporting this inverse
association, relative demographic data have already
been provided in many studies referring to patients
with CAE, in whom a low prevalence of diabetes was
noticed [81, 94]. Diabetes mellitus is known to pro-
mote negative remodeling in the arterial wall and
impairs compensatory arterial enlargement during
the course of the atherosclerotic process [47, 91]. It
is reasonable to expect such an inverse association
between diabetes mellitus and CAE. On the other
hand, this makes a contradictory situation being
positively associated with atherosclerosis and nega-
tively associated with CAE. This contradiction also
suggests that the pathogenesis underlying CAE is
not simply a variant of coronary atherosclerosis. In
accordance with these observations, increased preva-
lence of abdominal aortic aneurysm (AAA) has been
reported in patients without diabetes mellitus [13,
44]. Blanchard et al. [13] have reported that neither
clinical hypercholesterolemia nor serum levels of to-
tal cholesterol, low density lipoprotein cholesterol,
and high density lipoprotein cholesterol is associated
with AAA. However they have reported an inverse
association between diabetes mellitus and abdominal
aortic aneurysm. The results of this study suggest
that the risk factors for AAA may differ from those
for atherosclerosis and that atherosclerosis per se is
not an adequate explanation as the cause of AAA
[13].
A rare variant of CAE can be found as a congeni-
tal anomaly, independent of any cardiovascular risk
factor. Congenital CAE is frequently associated with
other cardiac anomalies such as bicuspid aortic
valve, aortic root dilatation, ventricular septal defect
or pulmonary stenosis [17, 90]. In addition, CAE
have been well documented in patients with cyanotic
congenital heart disease. These necropsy specimens
of dilated and tortuous coronary arteries showed
medial smooth muscle cell loss, increased medial
collagen and disrupted internal elastic lamina [17].
Comparison of angiographic findings
in CAE and CAD
CAE has a high coexistence with CAD. Approxi-
mately 85% of patients with CAE also have concomi-
tant stenosing CAD [21, 27, 77, 82]. In patients with
concomitant CAD, the right coronary artery is most
frequently involved in the ectatic process, followed
by the left anterior descending artery and the cir-
cumflex artery [21, 82]. The right coronary artery is
also the most commonly involved coronary artery in
patients with isolated CAE ranging from 45% to
75% [10, 14, 21, 50, 82].
However, with regard to CAD, the LAD is most
commonly affected, followed by the right coronary
and left circumflex artery [32]. Furthermore involve-
ment of the right coronary artery by the stenotic le-
sion is the least compared to left anterior descending
and left circumflex artery in Demopoulos’s report
[21]. In patients with CAD coexisting with CAE,
34% of the stenotic lesions were in the vessels af-
fected by the ectatic process, while 65% were in the
non-ectatic vessels [21].
It has also been demonstrated that total CAD se-
verity, expressed as the number of coronary stenotic
lesions per patient, is found to be equivalent in pa-
tients with CAD coexisting with and without CAE.
The two patient groups have a similar incidence of
one vessel, two vessel, and three vessel disease [21].
Patients with coronary ectasia and coronary obstruc-
tive disease are similar in any respect to those with
similar coronary obstructive disease, but without
ectasia [53]. On the other hand, Giannoglou et al.
found that patients with CAE exhibited higher rates
of CAD than those without CAE, a difference that
was statistically significant [32]. However, over the 9
year study period, burden of CAD increased mark-
edly in the same study in contrast to CAE whose
prevalence remained the same [32].
Underlying pathology of CAE in relation to CAD
The frequent coexistence of CAE with CAD and histo-
pathological findings resembling those of athero-
sclerosis have led to the conclusion that the mecha-
nism underlying the pathogenesis of CAE is a variant
of atherosclerosis. However, there are some differences
in the proven association with CAE compared to CAD.
These issues are summarized in Table 2.
Histological examination has been performed in
only a minority of studies [19, 53, 81, 94] typically re-
vealing marked destruction and reduction of the me-
dial elastic fibers with disruption of the internal and
external elastic laminae, usually out of proportion to
the degree of the intimal involvement. However, as
the histopathological characteristics are similar to
coronary atherosclerosis, there are obvious similari-
ties between the pathogenesis of CAE and CAD. On
the other hand, the loss of musculoelastic arterial wall
components in CAE was noticed to be unrelated to lo-
cal atheromatous burden [10, 94]. Nonatherosclerotic
forms of CEA have been described with an intact ves-
sel intima, but with extensive media degeneration
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lagen) [55, 65]. Thus, a functional loss of the muscu-
loelastic components of the coronary artery media is
considered to be the predominant aspect in the patho-
genesis of CAE [10, 53, 81].
Celik et al. [14] have shown an association between
increased carotid intima-media-thickness and isolated
CAE, suggesting that atherosclerosis may be involved
in the pathogenesis of isolated CAE. However, they
did not study patients with concomitant CAE and
CAD. Another ultrasonographic study has shown that
patients with CAE coexisting with CAD have a signif-
icantly lower carotid intima-media thickness com-
pared those with CAD and without CAE indicating
that the mechanism underlying CAE might differ from
the ones observed in atherosclerosis [99]. Interest-
ingly, decreased endothelium-independent vasodilata-
tion has been shown in patients with CAE and CAD
compared to those with CAD alone [3].
Some authors have suggested NO to play a role in
the formation of CAE, which is distinct from athero-
genesis. England [24, 25] has reported an increased
frequency of CAE in individuals who had been ex-
posed to herbicide sprays. A herbicide containing
acetylcholinesterase inhibitor directly stimulates NO
production by increasing acetylcholine. It has been
proposed that chronic nitrite exposure may cause
hyaline degeneration of the coronary artery intima–
media resulting in abnormal coronary dilatation. Jo-
hanning et al. [43] and Fukuda et al. [30] have ex-
perimentally shown that NO production plays a ma-
jor role in inflammation and aneurysm pathogenesis.
The overexpression of iNOS has been shown in vari-
cose veins together with an increased expression of
TGF-1 and the presence of macrophages [41]. It is
therefore interesting to note that the association of
peripheral varicose veins with CAE and varicocele
has been documented recently [46, 100].
NO production by iNOS occurs primarily by in-
flammatory cells resulting in high NO levels and
toxic products that degrade elastin and disrupt the
extracellular matrix [9, 60]. Inhibition of NO has
been shown to limit aneurysmal dilatation of the
aorta [43].
In accordance with these findings, Turhan et al.
have reported increased levels of C-reactive protein
and adhesion molecules indicating an increased in-
flammatory process in patients with isolated CAE
compared with both patients with and patients with-
out CAD [87, 88]. Furthermore, regarding the extra-
cellular matrix, Lamblin et al. [50] found that MMP-
3 5A/5A genotype was significantly more frequent in
patients with CAE than in the control group of CAD
patients. Increased MMP-3 activity is known to be
associated with structural alterations in the vessel
wall through the degradation of extracellular matrix
proteins such as proteoglycans, laminin, fibronectin
and collagen types III, IV, V and IX [23, 97]. Addi-
tionally, MMP-3 activity is increased in the wall of
aortic aneurysms [57, 100]. Finally, the recent obser-
vation that high circulating levels of MMP-3 are as-
sociated with coronary lesions in Kawasaki disease,
which is one of the underlying potential etiologies
of CAE [73], also supports an important role for
MMP-3 in the pathogenesis of CAE.
Arterial remodeling and CAE
Regarding the high coexistence of CAE and CAD,
positive remodeling described as enlargement of the
area within the external elastic membrane [34] may
play a role in the pathogenesis of CAE. Atheroscle-
rotic coronary arteries undergo expansive remodel-
ing to accommodate an increasing plaque burden,
especially during early stages of plaque accumulation
and following plaque rupture [34, 69]. One can re-
gard CAE as a consequence of extensive positive re-
modeling. However, this hypothesis remains to be
proven.
Systemic vascular involvement in patients
with CAE
Williams and Stewart [96] have suggested that, in
most patients, coronary ectasia is a diffuse disease
of the coronary arteries rather than a localized ab-
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Table 2 Differences between CAE and CAD with regard to disease charac-
teristics
Coronary
artery ectasia
CAE
Coronary
artery disease
CAD
Inversely associated risk factors
Diabetes mellitus
Age
+
+
–
–
More pronounced inflammatory parameters + –
Changes in extracellular matrix remodeling
MMP-3 5A polymorphism
Increased plasma levels of MMP-3
+
+
–
–
Involvement of coronary artery
Right coronary artery
Left anterior descending
+
–
–
+
Increased carotid intima-media thickness ± +
Decreased endothelium independent
dilatation
+–
Possible association with vein involvement + ±
Possible hazardous effect of nitrate
treatment
+–normality of a single arterial segment. Increased
‘thrombolysis in myocardial infarction’ (TIMI) frame
count, which is an angiographic definition describ-
ing the number of cineangiographic frames from ini-
tial contrast opacification of the proximal coronary
artery segment to opacification of distal arterial
landmarks [33], has been shown in both ectatic and
nonectatic coronary arteries [62, 72]. A similar find-
ing has also been reported using magnetic resonance
flow velocity [56]. Angiographic signs of turbulent
and stagnant flow include delayed antegrade dye fill-
ing, a segmental back flow phenomenon and local
deposition of dye (stasis) in the dilated coronary
segment [48, 53]. Slow flow has also been demon-
strated in the non-ectatic vessels of the same pa-
tients with CAE. Additionally, Akyurek et al. [4]
have demonstrated lower resting blood flow velocity
and coronary flow reserve by using the Doppler wire
(Flowire) in patients with isolated CAE. Following
intracoronary administration of papaverine, a potent
hyperemic stimulus, the coronary flow reserve was
1.51 in CAE compared with 2.67 in control arteries
(p<0.001), suggesting a combination of epicardial
flow disturbances and microvascular dysfunction as
the cause of myocardial ischaemia.
A generalized deficit of the wall of the entire arte-
rial system has already been assumed, as associa-
tions have been found between CAE and ectasias or
aneurysms in other parts of the arterial tree includ-
ing the abdominal aorta and peripheral arteries [51,
66, 76, 85]. Papadakis et al. [61] reported an associa-
tion between CAE and aneurysm of the ascending
aorta. They have found increased incidence of CAE
in patients with aneurysm of ascending aorta (26%)
compared to age-matched control group (5%). On
the contrary the incidence of CAD is significantly
lower in patients with aneurysm of ascending aorta
(26%) than in control group (73%). Additionally,
Stajduhar et al. [70] reported that all patients with
CAE and abdominal aneurysms had obstructive
CAD, whereas Papadakis et al. found this in only
38% of patients (8 out of 21) with CAE and ascend-
ing aortic aneurysms. A possible explanation for this
discrepancy may be that aneurysms of the ascending
aorta most often result from the process of cystic
medial degeneration, whereas atherosclerotic aneu-
rysms occur infrequently in this segment of the aor-
ta [61].
Coexistence of CAE with venous dilatation has
been described, including varicosities of the coro-
nary venous tree [10] and of the leg veins [85]. Re-
cently, increased prevalence of peripheral varicous
vein has been reported by Androulakis et al. [6] in
patients with CAE compared to those with CAD.
Histological examination of the varicosities usually
shows degeneration, fragmentation and loss of the
medial elastic tissue, fragmentation and reshape of
the collagen fiber network, accumulation of extracel-
lular matrix widely separating the hypertrophied
medial VSMC and thickening of the intima [58, 68,
84]. Recently, we have shown increased prevalence of
varicocele, which is pathologic dilatation of pampi-
niform plexus in patients with CAE compared to pa-
tients with CAD [99]. These findings have also sug-
gested that the mechanism underlying CAE might
affect not only the arterial system, but also the ve-
nous system in the body. Although some preexisting
intimal hyperplasia has been shown in the saphe-
nous veins of the patients who underwent coronary
bypass surgery [28], atherosclerosis is known to be a
disease of elastic arteries and medium and large size
muscular arteries [35]. The coexistence of CAE and
venous system dilatation raises the possibility that
there might be different pathogenic mechanism or
mechanisms between the pathogenesis of CAE and
atherosclerosis.
Clinical course and treatment of CAE
The clinical course of CAE mainly depends on
whether it is isolated or coexisted with CAD. No sig-
nificant differences existed between the patients with
CAD coexisting with CAE during a follow-up of 5
years [82]. Patients with coronary ectasia and coro-
nary obstructive disease are similar in every respect
to those with similar coronary obstructive disease
but without ectasia. Demopoulos et al. [21] have re-
ported comparable 2-year survival in patients with
and without CAE (96.7% vs 94.8%). Although there
is a measurable incidence of previous myocardial in-
farction, patients with pure ectasia have a good
prognosis [21].
Pure ectasia is not completely innocuous, since
there is an appreciable incidence of a previous myo-
cardial infarction and angina [21]. On the other
hand Baman et al. [8] used more stringent criteria
for identifying patients with CAE, reported a signifi-
cant adverse outcome among 276 patients they stud-
ied, with a 5-year survival of 71%.
Treatment modalities of CAE have been well re-
viewed by Manginas and Cokkinos [52]. Coronary
artery bypass grafting has been used for many years
for the treatment of significant CAD co-existing with
ectatic coronary segments. The presence of thrombus
within the CAE and the question of the necessity to
remove large aneurysms have led to the introduction
of a variety of operative procedures, including proxi-
mal and distal ligation, aneurysmorrhectomy and
even aneurysm resection [1, 92]. The post-operative
outcome, however, was uniformly good [37]. Autolo-
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tient with an aneurysm in the right coronary artery.
Although the immediate and long-term angiographic
evaluation after the covered stent implantation
showed complete sealing of the aneurysm without
restenosis [79], long-term benefits have not been
confirmed by trials.
Unlike the concomitant CAD and CAE, medical
treatment for isolated CAE is not readily described.
Since patients with isolated CAE or dilated coronaro-
pathy have considerable risk of myocardial infarction
due to microemboli and thrombotic occlusion [65],
the application of platelet inhibitors as prophylaxis
against ischemic syndromes is indispensable in all
forms of CEA [48, 89]. Although some authors pre-
viously suggested use of anticoagulant drugs in pa-
tients with CAE, there is no available data to date
[52]. Concerning the medical treatment of CAE, ni-
troglycerin should be discussed in details. In con-
trast to the NTG effect in stenotic CAD, where the
drug had been proven to restore myocardial isch-
emia in coronary sinus studies [78], nitroglycerin
can lead to aggravation of myocardial ischemia in
patients with CAE and without obstructive lesions
[48]. Kruger et al. demonstrated that nitroglycerin
(0.8 mg) provoked a further significant deterioration
of myocardial ischemia and a frank cardiac lactate
production. The results of their study strongly sug-
gest that nitroglycerin has no therapeutic benefit in
“dilated coronaropathy,” but it may lower the isch-
emic threshold [48]. Consequently, the administra-
tion of nitrates in “dilated coronaropathy” should be
avoided. Myocardial ischemia development in pa-
tients with isolated CAE has been shown to be de-
pended on heart rate; therefore, a reasonable thera-
peutic approach might be the administration of
beta-blockers due to their negative chronotropic ef-
fect and reduction of myocardial oxygen consump-
tion in the absence of vasodilation [40, 48].
Conclusion
Patients with CAE coexisting with CAD do not have
any known additional risk compared to those with
CAD only. However, even patients with isolated CAE
have an enhanced risk for cardiovascular events sec-
ondary to slow coronary blood flow, microemboli or
thrombosis. Based on the current knowledge on
CAE, it is not fully justified to conclude that CAE is
a definite variant of coronary atherosclerosis. Re-
garding the slow progression and complex manifes-
tation pattern of atherosclerosis, CAD at a certain
stage might result in aneurysmal dilatation, i.e. CAE
formation. This transition is unpredictable based on
our current knowledge. Alternatively, the atheroscle-
rotic process may be triggered at sites of CAE.
Because of the discrepancies between CAE and
CAD, and because of the association of CAE with
other dilating arterial and even venous vascular dis-
ease, we tend to regard CAE as a systemic vascular
wall abnormality rather then a simple variation of
atherosclerosis. In order to further clarify the mech-
anisms underlying the pathogenesis of CAE, more
clinical and histopathological studies are required.
In fact, every patient with CAE should be rigorously
evaluated for the involvement of other vascular terri-
tories in the dilating disease process, both in the ar-
terial as well as in the venous vascular system.
n Acknowledgment The authors wish to thank Dr Hasan Turhan,
Inonu University, Malatya, Turkey, for discussion.
336 Clinical Research in Cardiology, Volume 96, Number 6 (2007)
© Steinkopff Verlag 2007
References
1. Aboud A, Bossert T, Siggusch HH,
Gummert J (2006) Surgical treatment
o fmultiple atherosclerotic coronary
artery aneurysms in a patient with
acute myocardial infarction. Clin Res
Cardiol 95:1–4
2. Aintablian A, Hamby RI, Hoffman I,
Kramer RJ (1978) Coronary ectasia:
incidence and results of coronary by-
pass surgery. Am Heart J 96:309–315
3. Aksoy Y, Acikgoz N, Sivri N, et al
(2006) Decreased nitrate-mediated di-
latation in patients with coronary ar-
tery ectasia: an ultrasonographic
evaluation of brachial artery. Coron
Artery Dis 17:365–369
4. Akyurek O, Berkalp B, Sayin T, et al
(2003) Altered coronary flow proper-
ties in diffuse coronary artery ecta-
sia. Am Heart J 145:66–72
5. Androulakis AE, Andrikopoulos GK,
Kartalis AN, et al (2004) Relation of
coronary artery ectasia to diabetes
mellitus. Am J Cardiol. 93:1165–1167
6. Androulakis AE, Katsaros AA, Karta-
lis AN, et al (2004) Varicose veins are
common in patients with coronary
artery ectasia. Just a coincidence or a
systemic deficit of the vascular wall?
Eur J Vasc Endovasc Surg 27:519–524
7. Assmann G, Cullen P, Schulte H
(2002) Simple scoring scheme for cal-
culating the risk of acute coronary
events based on the 10-year follow-up
of the Prospective Cardiovascular
Münster (PROCAM) study. Circula-
tion 105:310–315
8. Baman TS, Cole JH, Devireddy CM,
Sperling LS (2004) Risk factors and
outcomes in patients with coronary
artery aneurysms. Am J Cardiol 93:
1549–1551
9. Beckman JS, Koppenol WH (1996)
Nitric oxide, superoxide, and peroxy-
nitrite: the good, the bad, and the
ugly. Am J Physiol 271:C1424–C1437337 E. Yetkin and J. Waltenberger
Coronary artery ectasia and coronary atherosclerosis
10. Befeler B, Aranda MJ, Embi A et al
(1977) Coronary artery aneurysms:
study of their etiology, clinical
course, and effect on left ventricular
function and prognosis. Am J Med
62:597–607
11. Bermu ´dez P, Palop EL, Martínez-
Luengas RL et al (2003) Coronary
ectasia: prevalence, and clinical and
angiographic characteristics. Revista
Espanola De Cardiologia 56:473–479
12. Binstadt BA, Levine JC, Nigrovic PA,
et al (2005) Coronary artery dilation
among patients presenting with sys-
temic-onset juvenile idiopathic arthri-
tis. Pediatrics 116:e89–e93
13. Blanchard JF, Armenian HK, Friesen
PP (2000) Risk factors for abdominal
aortic aneurysm: results of a case-
control study. Am J Epidemiol 151:
575–583
14. Celik S, Erdogan T, Kasap H, et al
(2007) Carotid intima-media thick-
ness in patients with isolated coro-
nary artery ectasia. Atherosclerosis
190:385–387
15. Chaithiraphan S, Goldberg E, O’Reilly
M (1973) Multiple aneurysms of
coronary artery in sclerodermal heart
disease. Angiology 24:86–93
16. Chakrabarti S, Thomas E, Wright JG,
Vettukattil JJ (2003) Congenital coro-
nary artery dilatation. Heart 89:595–
596
17. Chugh R, Perloff JK, Fishbein M,
Child JS (2004) Extramural coronary
arteries in adults with cyanotic con-
genital heart disease. Am J Cardiol
94:1355-1357
18. Dahdah NS, Fournier A, Jaeggi E, et
al (1999) Segmental myocardial con-
tractility versus perfusion in Kawasa-
ki disease with coronary arterial an-
eurysm. Am J Cardiol 83:48-51
19. Daoud AS, Pankin D, Tulgan H, Flor-
entin RA (1963) Aneurysms of the
coronary artery: report of ten cases
and review of the literature. Am J
Cardiol 11:228–237
20. Davidson A, Eshaghpour E, Young N,
Mintz GS (1991) Late thrombosis of a
coronary artery mycotic aneurysm.
Am Heart J 121:1549–1550
21. Demopoulos V, Olympios C, Fakiolas
C, et al (1997) The natural history of
aneurysmal coronary artery disease.
Heart 78:136–141
22. Dietl RH, Seggewiss H, Ohlmeier H,
et al (1996) Congenital coronary ar-
tery aneurysm: a rare cause of acute
myocardial infarct. Z Kardiol 85(3):
188–192
23. Dollery CM, McEwan JR, Henney AM
(1995) Matrix metalloproteinases and
cardiovascular disease. Circ Res 77:
863– 868
24. England JF (1981) Herbicides and
coronary artery ectasia. Med J Aust
1:140
25. England JF (1981) Herbicides and
coronary artery ectasia. Med J Aust
2:260
26. Falsetti HL, Carrol RJ (1976) Coro-
nary artery aneurysm: a review of
the literature with a report of 11 new
cases. Chest 69:630–636
27. Farto-e-Abreu P, Mesquita A, Silva
JA, Seabra Comez R (1993) Coronary
artery ectasia: clinical and angio-
graphic characteristics and prognosis.
Rev Port Cardiol 12:305–310
28. Friedl R, Li J, Schumacher B, et al
(2004) Intimal hyperplasia and ex-
pression of transforming growth fac-
tor-beta1 in saphenous veins and in-
ternal mammary arteries before coro-
nary artery surgery. Ann Thorac Surg
78:1312–1318
29. Fujiwara S, Emoto M, Komatsu M, et
al (2003) Arterial wall thickness is as-
sociated with insulin resistance in
type 2 diabetic patients. J Atheroscler
Thromb 10:246–252
30. Fukuda S, Hashimoto N, Naritomi H,
et al (2000) Prevention of rat cerebral
pseudoaneurysm formation by inhi-
bition of nitric oxide synthase. Circu-
lation 101:2532–2538
31. Gardiner DS, Lindop GB (1989)
Coronary artery aneurysm due to
primary cardiac lymphoma. Histo-
pathology 15:537–540
32. Giannoglou GD, Antoniadis AP, Chat-
zizisis YS, et al (2006) Prevalence of
Ectasia in Human Coronary Arteries
in Patients in Northern Greece Re-
ferred for Coronary Angiography.
Am J Cardiol 98:314–318
33. Gibson CM, Cannon CP and Daley
WL, et al (1996) TIMI frame count: a
quantitative method of assessing cor-
onary artery flow. Circulation 93:
879–888
34. Glagov S, Weisenberg E, Zarins CK,
et al (1987) Compensatory enlarge-
ment of human atherosclerotic coro-
nary arteries. N Engl J Med 316:
1371–1375
35. Goran KH, Jan H (2001) Pathogenesis
of atherosclerosis. In: Crawford MH,
DiMarco JP (eds) Cardiology. Mosby,
London Edinburg, pp 1–12
36. Harada H, Yamamoto N, Ueda M,
Abe T (1997) A clinical investigation
of Bentall’s operation for annuloaor-
tic ectasia in the elderly. Kyobu Geka
50(8 Suppl):632–636
37. Harandi S, Johnston SB, Wood RE,
Roberts WC (1999) Operative therapy
of coronary arterial aneurysm. Am J
Cardiol 83:1290–1293
38. Hartnell GG, Parnell BM, Pridie RB
(1985) Coronary artery ectasia: its
prevalence and clinical significance
in 4993 patients. Br Heart J 54:392–
395
39. Hiraishi S, Yashiro K, Oguchi K, et al
(1981) Clinical course of cardiovascu-
lar involvement in the mucocuta-
neous lymph node syndrome-relation
between the clinical signs of carditis
and development of coronary arterial
aneurysm. Am J Cardiol 47:323–330
40. Jackson G, Atkinson L and Oram S
(1977) Improvement of myocardial
metabolism in coronary arterial dis-
ease by beta-blockade. Br Heart J 39:
829–833
41. Jacob T, Hingorani A, Ascher E
(2005) Overexpression of transform-
ing growth factor-beta1 correlates
with increased synthesis of nitric ox-
ide synthase in varicose veins. J Vasc
Surg 41:523–530
42. Johanning JM, Armstrong PJ, Frank-
lin DP, et al (2002) Nitric oxide in ex-
perimental aneurysm formation: early
events and consequences of nitric ox-
ide inhibition. Ann Vasc Surg 16:65–
72
43. Johanning JM, Franklin DP, Han DC,
et al (2001) Inhibition of inducible
nitric oxide synthase limits nitric
oxide production and experimental
aneurysm expansion. J Vasc Surg 33:
579–586
44. Kang SS, Littooy FN, Gupta SR, et al
(1999) Higher prevalence of abdom-
inal aortic aneurysms in patients
with carotid stenosis but without dia-
betes. Surgery 126:687–691
45. Kannel WB, McGee DL (1979) Dia-
betes and cardiovascular disease: the
Framingham study. JAMA 241:2035–
2038
46. Kilic S, Aksoy Y, Sincer I, et al (2007)
Cardiovascular evaluation of young
patients with varicocele. Fertility and
Sterility (published online on Feb 16)
47. Kornowski R, Mintz GS, Lansky J, et
al (1998) Paradoxic decreases in ath-
erosclerotic plaque mass in insulin-
treated diabetic patients. Am J Cardi-
ol 81:1298–1304
48. Krueger D, Stierle U, Herrmann G, et
al (1999) Exercise-induced myocar-
dial ischaemia in isolated coronary
artery ectasias and aneurysms (‘Di-
lated Coronaropathy’). J Am Coll Car-
diol 34:1461–1470
49. Lam CSP and Ho KT (2004) Coro-
nary artery ectasia: a ten year experi-
ence in a tertiary hospital in Singa-
pore, Ann Acad Med Singapore 33:
419–422338 Clinical Research in Cardiology, Volume 96, Number 6 (2007)
© Steinkopff Verlag 2007
50. Lamblin N, Bauters C, Hermant X, et
al (2002) Polymorphisms in the pro-
moter regions of MMP-2, MMP-3,
MMP-9 and MMP-12 genes as deter-
minants of aneurysmal coronary
artery disease. J Am Coll Cardiol 40:
43–48
51. LaMendola CL, Culliford AT, Harris
LJ, Amendo MT (1990) Multiple an-
eurysms of the coronary arteries in a
patient with systemic aneurysmal dis-
ease. Ann Thorac Surg 49:1009–1010
52. Manginas A, Cokkinos DV (2006)
Coronary artery ectasias: imaging,
functional assessment and clinical
implications. Eur Heart J 27:1026–
1031
53. Markis JE, Joffe CD, Cohn PF, Feen
et al (1976) Clinical significance of
coronary arterial ectasia. Am J Car-
diol 37:217–222
54. Matayoshi AH, Dhond MR, Laslett LJ
(1999) Multiple coronary aneurysms
in a case of systemic lupus erythema-
tosus. Chest 116:1116–1168
55. Mattern AL, Baker WP, McHale JJ,
Lee DE (1972) Congenital coronary
aneurysms with angina pectoris and
myocardial infarction treated with sa-
phenous vein bypass graft. Am J Car-
diol 30:906–909
56. Mavrogeni SI, Manginas A, Papada-
kis E, et al (2005) Coronary flow
evaluation by TIMI frame count and
magnetic resonance flow velocity in
patients with coronary artery ectasia.
J Cardiovasc Magn Reson 7:545–550
57. Newman KM, Ogata Y, Malon AM, et
al (1994) Identification of matrix me-
talloproteinases 3 (stromelysin-1) and
9 (gelatinase B) in abdominal aortic
aneurysm. Arterioscler Thromb 14:
1315–1320
58. Niebes P (1996) Vessel wall modifica-
tion in venous pathology. Application
to the study of phlebotonic drugs. Int
Angiol 15:88–92
59. Noma M, Kikuchi Y, Yoshimura H, et
al (1993) Coronary ectasia in Takaya-
su’s arteritis. Am Heart J 126:459–461
60. Paik DC, Ramey WG, Dillon J, Tilson
MD (1997) The nitrite/elastin reac-
tion: implication for in vivo degen-
erative effects. Connect Tissue Res
36:241–251
61. Papadakis MC, Leontiadis E, Mangi-
nas A, et al (2004) Frequency of cor-
onary artery ectasia in patients un-
dergoing surgery for ascending aortic
aneurysms. Am J Cardiol 94:1433–
1435
62. Papadakis MC, Manginas A, Cotileas
P, et al (2001) Documentation of slow
coronary flow by the TIMI frame
count in patients with coronary ecta-
sia. Am J Cardiol 88:1030–1032
63. Pasterkamp G, Schoneveld AH, van
der Wal AC, et al (1998) Relation of
arterial geometry to luminal narrow-
ing and histologic markers for plaque
vulnerability: the remodeling para-
dox. J Am Coll Cardiol 32:655–662
64. Rajaram V, Pandhya S, Patel S, et al
(2004) Role of surrogate markers in
assessing patients with diabetes mel-
litus and the metabolic syndrome
and in evaluating lipid-lowering ther-
apy. Am J Cardiol 93:32C–48C
65. Rath S, Har-Zahav Y, Battler A, et al
(1985) Fate of non-obstructive aneur-
ysmatic coronary artery disease: an-
giographic and clinical follow-up re-
port. Am Heart J 109:785–791
66. Ruttimann M, Perez JP, Richard R, et
al (1997) Intracranial aneurysm and
coronary ectasia. Presse Med 26:
1141–1143
67. Satran A, Bart BA, Henry CR, et al
(2005) Increased prevalence of coro-
nary artery aneurysms among co-
caine users.Circulation 111:2424–2429
68. Schoen FJ and Cotran RS (1999)
Blood vessels (varicose veins) In:
Robbins SL, Cotran RS, Kumar V
(eds) Pathologic basis of disease (6th
ed), Saunders, London, pp 529
69. Schoenhagen P, Ziada KM, Kapadia
SR, et al (2000) Extent and direction
of arterial remodeling in stable ver-
sus unstable coronary syndromes: an
intravascular ultrasound study. Circu-
lation 101:598–603
70. Schoenhagen P, Vince DG, Ziada K,
et al (2000) Increased presence of
matrix-metalloproteinase 3 in human
coronary lesions with positive arterial
remodeling (abstr). J Am Coll Cardi-
ol 35 Suppl A:58A–59A
71. Seabra-Gomes R, Somerville J, Ross
DN, et al (1974) Congenital coronary
artery aneurysms. Br Heart J 36:329–
335
72. Senen K, Yetkin E, Turhan H, et al
(2004) Increased thrombolysis in
myocardial infarction frame counts in
patients with isolated coronary artery
ectasia. Heart Vessels 19:23–26
73. Senzaki H, Masutani S, Kobayashi J,
et al (2001) Circulating matrix metal-
loproteinases and their inhibitors in
patients with Kawasaki disease. Cir-
culation 104:860–863
74. Sharma SN, Kaul U, Sharma S, et al
(1990) Coronary arteriographic pro-
file in young and old Indian patients
with ischaemic heart disease: a com-
parative study. Indian Heart J 42:365–
369
75. Shiro I, Bannerman RM, Graf CJ,
Brennan JC (1969) Ehlers–Danlos
syndrome with multiple arterial le-
sions. Am J Med 47:967–977
76. Stajduhar KC, Laird JR, Rogan KM
and Wortham DC (1993) Coronary
arterial ectasia: increased prevalence
in patients with abdominal aortic an-
eurysm as compared to occlusive ath-
erosclerotic peripheral vascular dis-
ease. Am Heart J 125:86–92
77. Starc R, Janezic AS, Cijan A (1991)
Angiographic evidence of coronary
arteryectasia: our experience. Cor
Vasa 33:288–293
78. Steele RJ, Burggraf GW and Parker
JO (1975) Effects of isosorbide dini-
trate on response to atrial pacing in
coronary heart disease. Am J Cardiol
33:206–211
79. Stefanadis C, Toutouzas K, Tsiamis E,
Toutouzas P (2000) New stent design
for autologous venous graft-covered
stent preparation: first human appli-
cation for sealing of a coronary aneu-
rysm. Catheter Cardiovasc Interv 55:
222–227
80. Sudhir K, Ports TA, Amidon TM, et
al (1995) Circulation. Increased prev-
alence of coronary ectasia in hetero-
zygous familial hypercholesterolemia
91(5):1375–1380
81. Swanton RH, Thomas ML, Coltart DJ,
et al (1978) Coronary artery ectasia:
a variant of occlusive coronary arter-
iosclerosis. Br Heart J 40:393–400
82. Swaye PS, Fisher LD, Litwin P, et al
(1983) Aneurysmal coronary artery
disease. Circulation 67:134–138
83. Tang PHL, Segal AJ (1970) Polyarteri-
tis nodosa of infancy: fatal late com-
plications. JAMA 217:666–670
84. Travers P, Brookes CE, Evans J et al
(1996) Assessment of wall structure
and composition of varicose veins
with reference to collagen, elastin
and smooth muscle content. Eur J
Vasc Endovasc Surg 11:230–237
85. Triantafillidi H, Rizos I, Androulakis
A, et al (2001) Coronary artery ecta-
sia, aneurysm of the basilar artery
and varicose veins. Common presen-
tation or generalized defect of the
vessel wall? Angiology 52:287–291
86. Tunick PA, Slater J, Kronzon I, Glass-
man E (1990) Discrete atherosclerotic
coronary artery aneurysms: a study
of 20 patients. J Am Coll Cardiol 15:
279–282
87. Turhan H, Erbay AR, Yasar AS, et al
(2004) Comparison of C-reactive pro-
tein levels in patients with coronary
artery ectasia – vs – patients with ob-
structive coronary artery disease. Am
J Cardiol 94:1303–1306
88. Turhan H, Erbay AR, Yasar AS, et al
(2005) Plasma soluble adhesion mole-
cules; intercellular adhesion mole-
cule-1, vascular cell adhesion mole-
cule-1 and E-selectin levels in pa-
tients with isolated coronary artery
ectasia. Coron Artery Dis 16:45–50339 E. Yetkin and J. Waltenberger
Coronary artery ectasia and coronary atherosclerosis
89. Turhan H, Yetkin E (2007) What is
the plausible strategy for the manage-
ment of patients with isolated coro-
nary artery ectasia and myocardial
ischemia? Int J Cardiol 117:285–286
90. Ucar T, Atalay S, Tekin M, Tutar E
(2005) Bilateral coronary artery dila-
tation and supravalvular pulmonary
stenosis in a child with noonan syn-
drome. Pediatr Cardiol 26:848–850
91. Vavuranakis M, Stefanadis C, Tou-
touzas K, et al (1997) Impaired com-
pensatory coronary artery enlarge-
ment in atherosclerosis contributes to
the development of coronary artery
stenosis in diabetic patients. An in
vivo intravascular ultrasound study.
Eur Heart J 18:1090–1094
92. Vijayanagar R, Shafii E, DeSantis M,
et al (1994) Surgical treatment of cor-
onary aneurysms with and without
rupture. J Thorac Cardiovasc Surg
107:1532–1535
93. Vine N, Powell JT (1991) Metallopro-
teinases in degenerative aortic dis-
ease. Clin Sci (Colch) 81:233–239
94. Virmani R, Robinowitz M, Atkinson
JB, et al (1986) Acquired coronary ar-
terial aneurysms: an autopsy study of
52 patients. Hum Pathol 17:575–583
95. Wagenknecht LE, Zaccaro D, Espe-
land MA, et al (2003) Diabetes and
progression of carotid atherosclerosis:
the insulin resistance atherosclerosis
study. Arterioscler Thromb Vasc Biol
23:1035–1041
96. Williams MJA, Stewart RAH (1994)
Coronary artery ectasia: local pathol-
ogy or diffuse disease. Cathet Cardio-
vasc Diagn 33:116–119
97. Ye S, Eriksson P, Hamsten A, et al
(1996) Progression of coronary ather-
osclerosis is associated with a com-
mon genetic variant of the human
stromelysin-1 promoter which results
in reduced gene expression. J Biol
Chem 271:13055–13060
98. Yetkin E, Acikgoz N, Aksoy Y, et al
(2005) Decreased carotid intima–me-
dia thickness in patients with coro-
nary artery ectasia compared to pa-
tients with coronary artery disease.
Coron Artery Dis 16:495–498
99. Yetkin E, Kilic S, Acikgoz N, et al
(2005) Increased prevalence of vari-
cocele in patients with coronary
artery ectasia. Coron Artery Dis 16:
261–264
100. Zankl AR, Schumacher H, Katus HA,
et al (2007) Pathology, natural history
and treatment of abdominal aortic
aneurysms. Clin Res Cardiol 96:1–12